December 29, 2025

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A 12.42% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands out as a key player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of approximately $17.99 billion,..

The Cooper Companies, Inc. (COO): Investor Outlook on a Promising 9.54% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a stalwart in the Healthcare sector specializing in Medical Instruments & Supplies, presents a promising opportunity for investors, showcasing a potential upside of 9.54%...

CVS Health Corporation (CVS) Stock Analysis: Navigating Healthcare with an 18.83% Potential Upside

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, operating across multiple segments that collectively offer comprehensive health solutions. With a market capitalization of $101.06..

UnitedHealth Group (UNH) Stock Analysis: Growth Potential with 18.21% Upside

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, boasting a market capitalization of $300.58 billion. For investors looking to tap into the healthcare plans industry,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Healthcare Giant with a 10.87% Upside Potential

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the healthcare sector, is making waves in the medical devices industry. Headquartered in Watford, United Kingdom, this company has a..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 17.79% Potential Upside Amidst Revenue Challenges

Investors eyeing the biotechnology sector have their sights set on Moderna, Inc. (NASDAQ: MRNA), a prominent player in the development of messenger RNA (mRNA) medicines. Despite a challenging year marked..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unveiling a 22.8% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a heavyweight in the biotechnology industry, is currently captivating investor interest with its promising pipeline of RNA interference therapeutics. With a market capitalization of $52.92..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a 6.16% Upside Potential for Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a towering figure in the healthcare sector, continues to capture investor attention with its formidable presence in the drug manufacturing industry. With a market capitalization..

The Ensign Group, Inc. (ENSG): Investor Outlook with a 17.43% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $10.22 billion, this..

Encompass Health (EHC) Stock Analysis: A Healthcare Giant with a Potential 30% Upside

For investors seeking promising opportunities in the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a compelling case. As a leader in post-acute healthcare services, Encompass Health operates a vast..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 6.43% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a dynamic player in the healthcare sector, is capturing investor attention with its expansive portfolio and a potential upside of 6.43% as indicated by recent analyst..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Potential 49.69% Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leader in the biotechnology sector, continues to capture investor interest with its promising pipeline and robust portfolio of therapies for rare diseases and medical..

DaVita Inc. (DVA) Stock Analysis: Examining Growth Potential Amidst a 26.78% Upside

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector specializing in kidney dialysis services, presents an intriguing case for individual investors seeking growth potential. With a market capitalization..

Exact Sciences Corporation (EXAS) Investor Outlook: Navigating a Promising 2.95% Upside Amid Robust Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector with a keen focus on diagnostics and research, continues to capture investor attention. With its market capitalization reaching..

Genmab A/S (GMAB) Stock Analysis: Unpacking a Promising 13% Upside Potential in Biotech

Genmab A/S (GMAB), a leading biotechnology company based in Denmark, has been capturing the attention of investors with its robust pipeline of antibody-based therapies targeting cancer and other diseases. With..

Waters Corporation (WAT) Stock Analysis: Evaluating Growth Potential in Diagnostics & Research

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $22.99 billion and a robust..

Haleon plc (HLN) Stock Analysis: Evaluating a 15.72% Potential Upside for the UK Healthcare Giant

As investors navigate the volatile waters of the healthcare sector, Haleon plc (NYSE: HLN) emerges as an intriguing player with a substantial market capitalization of $45.11 billion. Positioned within the..

United Therapeutics Corporation (UTHR) Stock Analysis: Insights into a Healthcare Innovator with 2.19% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $22.94 billion,..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Powerhouse with an 18.22% Potential Upside

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is making significant strides in the diagnostics and research industry. With a market capitalization of $11.23 billion, Revvity offers..

Boston Scientific Corporation (BSX) Investor Outlook: 31% Upside Potential Amid Robust Revenue Growth

Boston Scientific Corporation (NYSE: BSX), a leading player in the medical devices industry, presents a compelling investment opportunity with a notable 31.02% potential upside, according to analyst ratings. With a..

Search

Funds

December 29, 2025

Search

Funds

December 29, 2025

FTSE 100

Funds